Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Early detection of sensory nerve function impairment in leprosy under field conditions

John AS, Govindharaj P. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2022;
Download PDF
Publication

Hanseníase: um problema além da cura

Silva ACMD, Jesus CSD, Dias AK, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (9) : e14611931660.
Download PDF
Publication

Validação de um instrumento simples e de aplicação rápida para rastrear incapacidade em pacientes com hanseníase

Pinho AB, Freitas MMD, Fontes CJF. Georg Thieme Verlag KG. Revista Brasileira de Ortopedia. 2022;
Download PDF
Publication

Peripheral neuropathy in leprosy: Clinical manifestations and disability in a Colombian national referral center.

Trujillo-Ramirez L, Palacios-Ariza M, Pradilla I, et al. Dermatology reports. 2022; 14 (2) : 9308.
Download PDF
Publication

Social participation restriction among persons with leprosy discharged from a multidrug therapy clinic in northern Nigeria.

Dahiru T, Iliyasu Z, Aliyu M. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2022;
Download PDF
Publication

Histopathology of SUMO in TGF-β1 signaling in neural lesions of leprosy reversal reactions

Yuniati R, Riawan W, Widayati A, et al. Lepra. Leprosy Review. 2022; 93 (2) : 138-148.
Download PDF
Publication

Remote disability and leprosy services via basic communications technology

Theint ZM, Htun ZL, Swe KM, et al. Lepra. Leprosy Review. 2022; 93 (2) : 166-171.
Download PDF
Publication

Clinical profile of patients with pure neuritic leprosy: 20 years’ experience at a tertiary referral centre from North India

Bhalla M, Poonia K, Jain S, et al. Lepra. Leprosy Review. 2022; 93 (2) : 131-137.
Download PDF
Publication

Hanseníase: Relação entre o diagnóstico precoce, número de lesões dermatológicas e grau de incapacidade no momento do diagnóstico no estado de Sergipe entre 2010 e 2020

Xavier LFF, Silva RRDS, Xavier BMF, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (7) : e30711730178.
Download PDF
Publication

Leprosy patients with deformities at post-elimination stage: The Bangladesh experience.

Mowla M, Angkur D, Hasan Z, et al. Skin health and disease. 2021; 1 (1) : e5.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 32
  • Next page ››
Subscribe to Disability

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD